165 related articles for article (PubMed ID: 8429263)
1. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia.
Dejager S; Bruckert E; Chapman MJ
J Lipid Res; 1993 Feb; 34(2):295-308. PubMed ID: 8429263
[TBL] [Abstract][Full Text] [Related]
2. Ciprofibrate therapy normalises the atherogenic low-density lipoprotein subspecies profile in combined hyperlipidemia.
Bruckert E; Dejager S; Chapman MJ
Atherosclerosis; 1993 Apr; 100(1):91-102. PubMed ID: 8318067
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
[TBL] [Abstract][Full Text] [Related]
4. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
[TBL] [Abstract][Full Text] [Related]
5. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation.
Chapman MJ; Laplaud PM; Luc G; Forgez P; Bruckert E; Goulinet S; Lagrange D
J Lipid Res; 1988 Apr; 29(4):442-58. PubMed ID: 3392462
[TBL] [Abstract][Full Text] [Related]
6. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families.
Liu ML; Ylitalo K; Nuotio I; Salonen R; Salonen JT; Taskinen MR
Stroke; 2002 May; 33(5):1255-60. PubMed ID: 11988600
[TBL] [Abstract][Full Text] [Related]
7. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a).
Lesnik P; Vonica A; Guérin M; Moreau M; Chapman MJ
Arterioscler Thromb; 1993 Jul; 13(7):1066-75. PubMed ID: 8318508
[TBL] [Abstract][Full Text] [Related]
10. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
[TBL] [Abstract][Full Text] [Related]
11. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
12. Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL.
Chancharme L; Thérond P; Nigon F; Lepage S; Couturier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):810-20. PubMed ID: 10073990
[TBL] [Abstract][Full Text] [Related]
13. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis.
Goulinet S; Chapman MJ
Arterioscler Thromb Vasc Biol; 1997 Apr; 17(4):786-96. PubMed ID: 9108795
[TBL] [Abstract][Full Text] [Related]
14. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants.
Brude IR; Drevon CA; Hjermann I; Seljeflot I; Lund-Katz S; Saarem K; Sandstad B; Solvoll K; Halvorsen B; Arnesen H; Nenseter MS
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2576-88. PubMed ID: 9409230
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.
Chait A; Brazg RL; Tribble DL; Krauss RM
Am J Med; 1993 Apr; 94(4):350-6. PubMed ID: 8475928
[TBL] [Abstract][Full Text] [Related]
16. Identification of multiple dense LDL subfractions with enhanced susceptibility to in vitro oxidation among hypertriglyceridemic subjects. Normalization after clofibrate treatment.
de Graaf J; Hendriks JC; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1993 May; 13(5):712-9. PubMed ID: 8485123
[TBL] [Abstract][Full Text] [Related]
17. The atherogenic role of triglycerides and small, dense low density lipoproteins: impact of ciprofibrate therapy.
Chapman MJ; Bruckert E
Atherosclerosis; 1996 Jul; 124 Suppl():S21-8. PubMed ID: 8831912
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
[TBL] [Abstract][Full Text] [Related]
19. Lipid compositional differences of small, dense low-density lipoprotein particle influence its oxidative susceptibility: possible implication of increased risk of coronary artery disease in subjects with phenotype B.
Ohmura H; Mokuno H; Sawano M; Hatsumi C; Mitsugi Y; Watanabe Y; Daida H; Yamaguchi H
Metabolism; 2002 Sep; 51(9):1081-7. PubMed ID: 12200749
[TBL] [Abstract][Full Text] [Related]
20. LDL physical and chemical properties in familial combined hyperlipidemia.
Hokanson JE; Krauss RM; Albers JJ; Austin MA; Brunzell JD
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):452-9. PubMed ID: 7749856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
